ZKAB001
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ZKAB001, covering 2018-09-26 to 2024-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC [Phase 3]